Polycystic Ovary Syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 18 - 40 years 25 = body mass index(BMI) = 34.9 Women with PCOS diagnosed by the Rotterdam criteria
Exclusion criteria
Exclusion criteria: pregnant or lactating night-shift workers, hypotension use of medication therapy that impacts carbohydrate or lipid metabolism (oral contraceptive pills, insulin-sensitizers, antiepileptics, statins, fish oil and ...) in the recent 3 months body weight fluctuations for more than 5% in the past 3 months Medicines that affect body weight Regular use of any drug or supplement that affects sleep Taking drugs that affect appetite at the time of entering the study Having a special diet Eating disorders or mental disorders night eating syndrome fasting for more than 14 h per day Congenital adrenal hyperplasia, androgen-secreting tumor, Cushing's syndrome, diabetes, thyroid dysfunction and hyperprolactinemia Cardiovascular, kidney, liver, lung and nervous diseases, digestive system surgery or food absorption disorders professional athlete perimenopausal Tobacco history Taking food supplements Sarcopenia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting Blood Sugar. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Biochemical analysis of blood sample.;Fasting Insulin. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Biochemical analysis of blood sample.;Insulin resistance. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Calculation of Homeostatic Model Assessment (HOMA).;Total cholesterol. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Biochemical analysis of blood sample.;Triglyceride. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Biochemical analysis of blood sample.;High-density lipoprotein (HDL). Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Biochemical analysis of blood sample.;Low-density lipoprotein (LDL). Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Biochemical analysis of blood sample.;Appetite. Timepoint: beginning, middle and end of study (every two weeks). Method of measurement: Visual Analog Scale (VAS) questionnaire.;Sleep quality. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Petersburg’s sleep quality questionnaire.;Body weight. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: scale.;Waist circumference. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Meter.;Body mass index (BMI). Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Weight in kilograms divided by height squared in meters. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body composition. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: Bioelectric Impedance Analysis (BIA) device.;Eating behavior. Timepoint: At the beginning and end of the study (after 6 weeks). Method of measurement: The Three-Factor Eating Questionnaire.;Energy intake. Timepoint: beginning, middle and end of study (every two weeks). Method of measurement: 24-hour Dietary Recall.;Carbohydrate intake. Timepoint: beginning, middle and end of study (every two weeks). Method of measurement: 24-hour Dietary Recall.;Protein intake. Timepoint: beginning, middle and end of study (every two weeks). Method of measurement: 24-hour Dietary Recall.;Fat intake. Timepoint: beginning, middle and end of study (every two weeks). Method of measurement: 24-hour Dietary Recall. | — |
Countries
Iran (Islamic Republic of)
Contacts
Oroumia University of Medical Sciences